Molecular grafting onto a stable framework yields novel cyclic peptides for the treatment of multiple sclerosis.

Molecular grafting onto a stable framework yields novel cyclic peptides for the treatment of multiple sclerosis.

  • Post by:
  • 16 May 2019
  • Comments off
Categories: